这是描述信息
搜索

Discovery

All categories

Hybridoma

  • Categories:Discovery
  • Time of issue:2021-02-08 16:38:20
  • Views:0
Description:
Description:
Information

Antibody discovery

In KYinno, more than 50 scientists are dedicated to offer a comprehensive and integrated antibody solution, including target discovery and validation, antigen design and preparation, Hybridoma/Phage display/Single B cell, high throughput antibody screening, functional validation, humanization and recombinant expression. With our unique technologies, antibodies for many hard targets, such as GPCR and Ion channel, have been successfully generated.

 

Hybridoma 
High efficient Electronic fusion can yield over 10,000 hybridoma per fusion. Positive rate is up to 90%. With fast protocol, including specific immunization approach, positive hybridoma can be obtained in 60 days.  

 

Example:
GPCR target:GPRC5D
With unique GPCR antibody discovery technologies, high affinity/specific monoclonal antibodies can be generated within 60 days.

KYinno

 KYinno Biotechnology Co., Ltd

Cell phone No: +(86)10-58222701 / 58222702

Room 609, No.3 Building, Yizhuang Biomedical Park, No.88, Kechuang Six Street, BDA,

 

Beijing, China, 101111

Email: bd@kyinno.com 

KYinno   京ICP备17041979号    www.300.cn